Economics professor Steinar Holden believes urgent changes to the vaccination plan are needed as the Johnson & Johnson vaccine will not arrive in Europe as planned.
Holden, who heads the expert group that has assessed the corona pandemic’s socio-economic consequences, believes that the vaccines in Norway should be distributed differently, Norwegian Broadcasting (NRK) reports.
“Now, there will be greater scarcity of vaccines. Therefore, it is even more important that the vaccines are used effectively. There are two measures that can contribute to this – a longer waiting period between doses one and two, and a different geographical distribution,” he said.
There have been high expectations and hopes for the Johnson & Johnson vaccine, but after several reports of serious side effects, the vaccine’s delivery to Europe has been paused.
That means that vaccination in Norway could be delayed for up to twelve weeks. In June alone, one million doses were expected from Johnson & Johnson, according to the National Institute of Public Health (FHI).
“It does not surprise me. So far, it has gone very fast, and we have been very lucky. The fact that there will be obstacles along the way must be taken into account,” immunologist and professor Anne Spurkland at the University of Oslo noted.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "Norwegian professor: The vaccination schedule should be changed after the Johnson & Johnson vaccine issues"